Cargando…

Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies

Invasive meningococcal disease (IMD) imposes a significant burden on the global community due to its high case fatality rate (4-20%) and the risk of long-term sequelae for one in five survivors. An expert group meeting was held to discuss the epidemiology of IMD and immunization policies in Malaysia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thisyakorn, Usa, Carlos, Josefina, Chotpitayasunondh, Tawee, Dien, Tran M., Gonzales, Maria Liza A. M., Huong, Nguyen T. L., Ismail, Zulkifli, Nordin, Musa M., Ong-Lim, Anna Lisa T., Tantawichien, Terapong, Terumalay, Sangita D., Vu, Thiem D., Cintra, Otavio, Oladehin, Olakunle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Meningococcal – Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746482/ https://www.ncbi.nlm.nih.gov/pubmed/36084311 http://dx.doi.org/10.1080/21645515.2022.2110759

Ejemplares similares

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination
por: Tan, Litjen (L.J), et al.
Publicado: (2023)

Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam
por: The Nguyen, Phung Nguyen, et al.
Publicado: (2023)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Meningococcal burden of disease in Argentina: 10 years epidemiologic review
por: Neyro, Silvina, et al.
Publicado: (2023)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
por: Robertson, Corwin A., et al.
Publicado: (2023)

Meningococcal carriage in the African meningitis belt
Publicado: (2013)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
por: Marshall, Gary S., et al.
Publicado: (2022)

Real-world impact and effectiveness of MenACWY-TT
por: Villena, Rodolfo, et al.
Publicado: (2023)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
por: Chotpitayasunondh, Tawee, et al.
Publicado: (2008)

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2022)

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
por: Piazza, Franco M., et al.
Publicado: (2021)

Dengue
por: Tantawichien, Terapong, et al.
Publicado: (2018)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
por: Dubey, Anand P., et al.
Publicado: (2022)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
por: Stefanizzi, Pasquale, et al.
Publicado: (2021)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

Dengue fever and dengue haemorrhagic fever in adolescents and adults
por: Tantawichien, Terapong
Publicado: (2012)

Proceedings of the 5th Asia Dengue Summit
por: Srisawat, Nattachai, et al.
Publicado: (2023)

Seroprevalence of leptospirosis among blood donors in an endemic area
por: Limothai, Umaporn, et al.
Publicado: (2023)

Discovery and validation of circulating miRNAs for the clinical prognosis of severe dengue
por: Limothai, Umaporn, et al.
Publicado: (2022)

Meningococcal carriage in children and young adults in the Philippines: a single group, cross-sectional study
por: GONZALES, M. L. A., et al.
Publicado: (2017)

Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area
por: Limothai, Umaporn, et al.
Publicado: (2021)

Serum Cortisol as a Biomarker of Severe Dengue
por: Bongsebandhu-phubhakdi, Chansuda, et al.
Publicado: (2023)

Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model
por: Régnier, Stéphane A, et al.
Publicado: (2014)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
por: Stefanizzi, Pasquale, et al.
Publicado: (2022)

Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia
por: Mohammed, Hassen, et al.
Publicado: (2021)

Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults
por: Díez-Domingo, Javier, et al.
Publicado: (2021)

World Dengue Day: A call for action
por: Srisawat, Nattachai, et al.
Publicado: (2022)

Infection Prevention and Control in Asia: Current Evidence and Future Milestones
por: Apisarnthanarak, Anucha, et al.
Publicado: (2017)

Serum Aminotransferases in Thai Children With Dengue Infection
por: Prommalikit, Olarn, et al.
Publicado: (2015)

Proceedings of the Dengue Symposium at the 9th International Congress of Tropical Pediatrics
por: Thisyakorn, Usa, et al.
Publicado: (2012)

Dengue amid COVID-19 pandemic
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rjm9dfkp2s589u2pev3kall822